All Stories

  1. Spatially resolved T cell receptor diversity mapping uncovers variability of the cancer immune microenvironment
  2. Targeted sequencing of mutations via RNA-templated gap filling of oligonucleotides for single-cell RNA-seq
  3. gSV: a general structural variant detector using the third-generation sequencing data
  4. Direct Inference of Haplotypes from Sequencing Data
  5. Optimizing Xenium In Situ data utility by quality assessment and best-practice analysis workflows
  6. Imaging flow cytometry with a real-time throughput beyond 1,000,000 events per second
  7. MRRM: Advanced Biomarker Alignment in Multi-Staining Pathology Images via Multi-Scale Ring Rotation-Invariant Matching
  8. BVSim: A benchmarking variation simulator mimicking human variation spectrum
  9. Parallel Analyses by Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) Reveal Complementary Proteomic Profiles in Triple‐Negative Breast Cancer (TNBC) Patient Tissues and Cell Cultures
  10. cascAGS: Comparative Analysis of SNP Calling Methods for Human Genome Data in the Absence of Gold Standard
  11. CellSAM: Advancing Pathologic Image Cell Segmentation via Asymmetric Large‐Scale Vision Model Feature Distillation Aggregation Network
  12. Proteomics Landscape of Triple-Negative Apocrine Breast Carcinoma Reveals Molecular Mechanisms of Tumorigenesis and Characteristics of Chemo-insensitivity
  13. Bridging Discoveries and Treatments: The New Landscape of Breast Cancer Research
  14. Parallel Analyses by Mass Spectrometry (MS) and Reverse Phase Protein Array (RPPA) Reveal Complementary Proteomic Profiles in Triple-Negative Breast Cancer (TNBC) Patient Tissues and Cell Cultures
  15. MSGM: An Advanced Deep Multi-Size Guiding Matching Network for Whole Slide Histopathology Images Addressing Staining Variation and Low Visibility Challenges
  16. Loss of Human Epidermal Receptor 2 Expression in Formalin-Fixed Paraffin-Embedded Breast Cancer Samples and the Rescuing Effect of Enhanced Antigen Retrieval and Signal Amplification
  17. An orientation-free ring feature descriptor with stain-variability normalization for pathology image matching
  18. Author Correction: The landscape of viral associations in human cancers
  19. Author Correction: Butler enables rapid cloud-based analysis of thousands of human genomes
  20. Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
  21. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  22. Author Correction: Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
  23. Author Correction: Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
  24. Author Correction: Pan-cancer analysis of whole genomes
  25. Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
  26. Author Correction: Genomic basis for RNA alterations in cancer
  27. Author Correction: Patterns of somatic structural variation in human cancer genomes
  28. Author Correction: The evolutionary history of 2,658 cancers
  29. Author Correction: The repertoire of mutational signatures in human cancer
  30. Biomarker Alteration after Neoadjuvant Endocrine Therapy or Chemotherapy in Estrogen Receptor-Positive Breast Cancer
  31. Author Correction: A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
  32. Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower
  33. Author Correction: Divergent mutational processes distinguish hypoxic and normoxic tumours
  34. Author Correction: Genomic footprints of activated telomere maintenance mechanisms in cancer
  35. Author Correction: Inferring structural variant cancer cell fraction
  36. Author Correction: Integrative pathway enrichment analysis of multivariate omics data
  37. Author Correction: Pathway and network analysis of more than 2500 whole cancer genomes
  38. Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
  39. Author Correction: High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
  40. Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
  41. Adverse Events of PD-1 or PD-L1 Inhibitors in Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis
  42. Survival in Breast Cancer Patients with Bone Metastasis: A Multicenter Real-World Study on the Prognostic Impact of Intensive Postoperative Bone Scan after Initial Diagnosis of Breast Cancer (CSBrS-023)
  43. Assessment of accuracy in identifying structural variants using third-generation sequencing for breast cancer in the absence of gold standard
  44. AR Expression Correlates with Distinctive Clinicopathological and Genomic Features in Breast Cancer Regardless of ESR1 Expression Status
  45. Germline Variants in 32 Cancer-Related Genes among 700 Chinese Breast Cancer Patients by Next-Generation Sequencing: A Clinic-Based, Observational Study
  46. Two-Dose Vaccination Significantly Prolongs the Duration from Symptom Onset to Death: A Retrospective Study Based on 173,894 SARS-CoV-2 Cases in Khyber Pakhtunkhwa, Pakistan
  47. Tunable mechanical and degradation properties of biodegradable Mg-Y-Zn alloys via Zn content regulation
  48. HER2-low-positive features a distinct subtype in estrogen receptor-positive breast cancer associated with endocrine therapy resistance
  49. Expression of DNA Helicase Genes Was Correlated with Homologous Recombination Deficiency in Breast Cancer
  50. BM-Net: CNN-Based MobileNet-V3 and Bilinear Structure for Breast Cancer Detection in Whole Slide Images
  51. Androgen receptor expression associates with distinctive clinicopathological and molecular features in ER-positive and ER-negative breast cancer
  52. Intraparenchymal breast leiomyoma and atypical leiomyoma
  53. Detection of Structural Variations and Fusion Genes in Breast Cancer Samples Using Third-Generation Sequencing
  54. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  55. Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy
  56. The natural history of breast cancer: a chronological analysis of breast cancer progression using data from the SEER database
  57. Triple negative apocrine breast carcinoma has better prognosis despite poor response to neoadjuvant chemotherapy
  58. Modeling effective tumor burden of primary lesion and metastatic lymph node in breast cancer patients from the SEER database
  59. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  60. Detection of structural variations and fusion genes in breast cancer samples using third-generation sequencing
  61. Identification and Functional Characterization of a Novel Nonsense Variant in ARR3 in a Southern Chinese Family With High Myopia
  62. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  63. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database
  64. Androgen Receptor Expression Associates With Distinctive Clinicopathological and Molecular Features in ER-Positive and ER-Negative Breast Cancer
  65. Detection of structural variations and fusion genes in breast cancer samples using third-generation sequencing
  66. Intraparenchymal Breast Leiomyoma and Atypical Leiomyoma
  67. Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores
  68. Prognosis classification of breast cancer with distant lymph node metastasis IIIc or M1 category
  69. Evaluating and Balancing the Risk of Breast Cancer-Specific Death and Other Cause-Specific Death in Elderly Breast Cancer Patients
  70. A Histone Acetylation Modulator Gene Signature for Classification and Prognosis of Breast Cancer
  71. Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapy
  72. Protective effect of goserelin on ovarian reserve during (neo)adjuvant chemotherapy in young breast cancer patients: a prospective cohort study in China
  73. RECQL5 KIX domain splicing isoforms have distinct functions in transcription repression and DNA damage response
  74. A Machine Learning Approach to Differentiate Two Specific Breast Cancer Subtypes Using Androgen Receptor Pathway Genes
  75. Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  76. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
  77. Sex differences in oncogenic mutational processes
  78. Highly Recurrent Copy Number Variations in GABRB2 Associated With Schizophrenia and Premenstrual Dysphoric Disorder
  79. Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  80. Publisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
  81. Detecting viruses in tumour tissue to discover links between cancer and infection
  82. Inferring structural variant cancer cell fraction
  83. Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
  84. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes
  85. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis
  86. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns
  87. Combined burden and functional impact tests for cancer driver discovery using DriverPower
  88. Divergent mutational processes distinguish hypoxic and normoxic tumours
  89. Genomic footprints of activated telomere maintenance mechanisms in cancer
  90. High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations
  91. Integrative pathway enrichment analysis of multivariate omics data
  92. Pathway and network analysis of more than 2500 whole cancer genomes
  93. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
  94. Comprehensive molecular characterization of mitochondrial genomes in human cancers
  95. Disruption of chromatin folding domains by somatic genomic rearrangements in human cancer
  96. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
  97. Butler enables rapid cloud-based analysis of thousands of human genomes
  98. Genomic basis for RNA alterations in cancer
  99. Patterns of somatic structural variation in human cancer genomes
  100. The repertoire of mutational signatures in human cancer
  101. Pan-cancer analysis of whole genomes
  102. The evolutionary history of 2,658 cancers
  103. Genomic subtyping of liver cancers with prognostic application
  104. Natural History of Breast Cancer: Reanalyze Nodal Stage and Oestrogen Receptor Status Affecting the Progression of Breast Cancer from SEER Database
  105. Transcriptional regulation of Bcl-2 gene by the PR/SET domain family member PRDM10
  106. Characteristics and Prognostic Factors of Patients With Osteosarcoma Older Than 60 Years From the SEER Database
  107. AluScanCNV2: An R package for copy number variation calling and cancer risk prediction with next-generation sequencing data
  108. Forward and reverse mutations in stages of cancer development
  109. Forward-reverse mutation cycles between stages of cancer development
  110. Coevolution Theory of the Genetic Code at Age Forty: Pathway to Translation and Synthetic Life
  111. Tripartite genome of all species
  112. Feature co-localization landscape of the human genome
  113. GABRB2 Haplotype Association with Heroin Dependence in Chinese Population
  114. Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response
  115. The genetic equidistance result: misreading by the molecular clock and neutral theory and reinterpretation nearly half of a century later